Computed tomographic angiography measures of coronary plaque in clinical trials: opportunities and considerations to accelerate drug translation

Atherosclerotic coronary artery disease (CAD) is the causal pathological process driving most major adverse cardiovascular events (MACE) worldwide. The complex development of atherosclerosis manifests as intimal plaque which occurs in the presence or absence of traditional risk factors. There are nu...

ver descrição completa

Detalhes bibliográficos

Principais autores:	N. Howden, K. Branch, P. Douglas, M. Gray, M. Budoff, M. Dewey, D. E. Newby, S. J. Nicholls, R. Blankstein, S. Fathieh, S. M. Grieve, G. A. Figtree
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-03-01
coleção:	Frontiers in Cardiovascular Medicine
Assuntos:	coronary plaque coronary CT drug development atherosclerosis CCTA
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fcvm.2024.1359500/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!